United States · FDA National Drug Code directory

SPIRONOLACTONE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63629-1830_e2c30b41-efb4-4443-8a4b-d6bbfc2132a1
Product NDC
63629-1830
Form
TABLET
Composition / generic term
SPIRONOLACTONE
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
19860723 / 20290228

Source-listed ingredients

  • SPIRONOLACTONE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (63629-1830-1) · 63629-1830-1
  • 60 TABLET in 1 BOTTLE (63629-1830-2) · 63629-1830-2
  • 90 TABLET in 1 BOTTLE (63629-1830-3) · 63629-1830-3
  • 14 TABLET in 1 BOTTLE (63629-1830-4) · 63629-1830-4
  • 100 TABLET in 1 BOTTLE (63629-1830-5) · 63629-1830-5
  • 7 TABLET in 1 BOTTLE (63629-1830-6) · 63629-1830-6
  • 10 TABLET in 1 BOTTLE (63629-1830-7) · 63629-1830-7
  • 180 TABLET in 1 BOTTLE (63629-1830-8) · 63629-1830-8
  • 45 TABLET in 1 BOTTLE (63629-1830-9) · 63629-1830-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →